You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 12, December 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Gastrointestinal/ Upper Foregut
 •Thoracic Surgery
 •Review
 •Gastrointestinal Diseases
 •Alert me on articles by topic

Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer

Mitsuo Tachibana, MD; Shoichi Kinugasa, MD; Hiroshi Yoshimura, MD; Dipok Kumar Dhar, MD; Naofumi Nagasue, MD

Arch Surg. 2003;138:1383-1389.

Objective  To review the surgical outcomes of extended esophagectomy with 3-field lymph node dissection (3FLND) for esophageal cancer.

Data Sources  Only articles written in English and written after 1980 were selected from MEDLINE. The following terms were identified: 3FLND, extensive or extended lymph node dissection (lymphadenectomy), radical lymph node dissection, cervical lymph node dissection, and extended or radical esophagectomy in esophageal cancer.

Study Selection  There were no exclusion criteria for published information relevant to the topic. The most representative articles were selected when there were several articles from the same institution. Case reports were excluded.

Data Extraction  Twenty-six articles were finally col-lected from MEDLINE. Eleven articles were also selected from reference lists of the pertinent literature.

Data Synthesis  The collected information was organized.

Conclusions  The conclusions drawn from those articles showed that extended esophagectomy with 3FLND would be a safe procedure in experienced hands, with low morbidity and acceptable mortality rates. When strict patient selection criteria were maintained, this procedure reduced locoregional recurrence and improved long-term survival rates. Although the therapeutic value of 3FLND is unproved in a randomized trial, extended esophagectomy with 3FLND would be the treatment of choice in selected patients.


From the Second Department of Surgery, Shimane Medical University, Shimane, Japan.


RELATED ARTICLE

Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer—Invited Critique
David M. Follette
Arch Surg. 2003;138(12):1390.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma.
Tachibana et al.
Eur. J. Cardiothorac. Surg. 2008;34:427-431.
ABSTRACT | FULL TEXT  

Clinicopathologic Features of Superficial Esophageal Cancer: Results of Consecutive 100 Patients
Tachibana et al.
Ann. Surg. Oncol. 2008;15:104-116.
ABSTRACT | FULL TEXT  

Appraisal of a Revised Lymph Node Classification System for Esophageal Squamous Cell Cancer
Dhar et al.
Ann. Thorac. Surg. 2007;83:1265-1272.
ABSTRACT | FULL TEXT  

Lymphadenectomy extent is closely related to long-term survival in esophageal cancer
Kang et al.
Eur. J. Cardiothorac. Surg. 2007;31:154-160.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.